Skip to content

13F-HR/A filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR/A for the quarter ended 2023-06-30, filed 2023-08-14, with 37 holding rows worth $341,630,357.

Accession
0001420506-23-001664
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, amendment of type restatement, 37 entries on the cover page, a total value of $341,630,357 stated on the cover page (in dollars after the unit check, H1), rows summing to $341,630,357 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PACIRA BIOSCIENCES INC COM695127100Stock877,586$35,164,871dollars as filed
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK4,078,804$27,409,563dollars as filed
HUMANA INC COM444859102Stock55,100$24,636,863dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM2,761,468$21,428,992dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock2,500,000$17,600,000dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM675,000$17,462,250dollars as filed
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR417,500$16,975,550dollars as filed
ABCELLERA BIOLOGICS INC COM00288U106Stock2,550,000$16,473,000dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM170,000$16,031,000dollars as filed
KURA ONCOLOGY INC COM50127T109Stock1,343,359$14,212,738dollars as filed
CENTENE CORP DEL COM15135B101Stock195,670$13,197,942dollars as filed
ADC THERAPEUTICS SAH0036K147COMMON STOCK5,583,900$12,005,385dollars as filed
KEZAR LIFE SCIENCES INC49372L100COM4,651,920$11,397,204dollars as filed
QUIDELORTHO CORP COM219798105Stock110,468$9,153,378dollars as filed
PROTHENA CORP PLC SHSG72800108Stock120,000$8,193,600dollars as filed
NANOSTRING TECHNOLOGIES INC63009R109COM2,000,000$8,100,000dollars as filed
OPTION CARE HEALTH INC COM NEW68404L201Stock235,780$7,660,492dollars as filed
UnitedHealth Group Inc91324P102COM15,000$7,209,600dollars as filed
INARI MED INC45332Y109COM118,684$6,900,288dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK2,109,620$6,582,014dollars as filed
LONGBOARD PHARMACEUTICALS IN54300N103COM734,897$5,394,144dollars as filed
Medtronic PlcG5960L103COM60,000$5,286,000dollars as filed
ALKERMES PLCG01767105SHS147,554$4,618,440dollars as filed
GRAPHITE BIO INC38870X104COM1,700,000$4,420,000dollars as filed
ERASCA INC COM29479A108Stock1,557,370$4,298,341dollars as filed
MARAVAI LIFESCIENCES HLDGS A56600D107COMMON STOCK314,300$3,906,749dollars as filed
IRHYTHM HOLDINGS INC COM450056106Stock36,030$3,758,650dollars as filed
COMPASS THERAPEUTICS INC20454B104COM1,083,997$3,447,110dollars as filed
NUVATION BIO INC COM CL A67080N101Stock1,100,000$1,980,000dollars as filed
TELADOC HEALTH INC87918A105COM76,900$1,947,108dollars as filed
AGILON HEALTH INC00857U107COM100,000$1,734,000dollars as filed
ALDEYRA THERAPEUTICS INC01438T106COM149,511$1,254,397dollars as filed
ELUTIA INC05479K106CL A COM324,425$765,643dollars as filed
ModivCare Inc60783X104Common Stock16,023$724,400dollars as filed
STARLING ONCOLOGY INC68236X100COMMON STOCK455,302$250,507dollars as filed
TRINET GROUP INC896288957PUT1,604,993$40,138dollars as filedput
ALDEYRA THERAPEUTICS INC01438T906COM671,200$10,000dollars as filedcall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-23-001564 superseded2023-08-14acceptance time not in the bulk data set
13F-HR/A 0001420506-23-001664this filing2023-08-14acceptance time not in the bulk data set